Editor’s Note: This is the second installment in our new Hidden Figures of Drug History series, with more to come in the future. Next week Points will feature more exciting news about drug and alcohol history in the media, as well as a great recap of LSD use in New York City in the 1960s. Enjoy this post and come back next week for more!
There are few subjects I like writing about more than the National Commission on Marihuana and Drug Abuse’s 1972 report, “Marihuana: A Signal of Misunderstanding.” Also known as the Shafer Commission, the group’s report enlivened my book Grass Roots, and I’ve continued to mine it for material on how we can understand the Trump administration’s response to the opioid overdose epidemic today.
But there’s something of particular interest for those who want to understand the role gender has long played in American drug history within this report as well. And that’s a name that appears within the list of the commission’s thirteen members, nine of whom were appointed by President Richard Nixon, and four of whom were senators and members of Congress.
And that name is Mrs. Joan Ganz Cooney.
Continue reading →
Editor’s Note: Discussing the history he wrote about in Tuesday’s post, “From Calcutta in 1890 to Canada Today: Exercises in Cannabis Legalization,” Peter Hynd explores more on this topic in a video taken at the Cannabis: Global Histories conference, held at the University of Strathclyde, Glasgow, from April 19-20, 2018. Video by Morgan Scott, Breathe Images. Enjoy!
Editor’s Note: Today’s post comes from Peter Hynd, a PhD candidate in history at McGill University in Quebec, based on the paper he presented at the Cannabis: Global Histories conference held at the University of Strathclyde, Glasgow, on April 19-20, 2018. In it, he explores how Calcutta legalized the sale of cannabis in the 19th century, and shows how the Indian government sought to implement legalization in the most effective (and profitable) way. Enjoy!
Imagine strolling up to a licensed cannabis shop and purchasing a few grams of the finest Government stamped and sealed ganja, no questions asked.
In your mind, where are you? Denver, Colorado in 2015? Montreal, Quebec, later this year?
How about Calcutta in 1890?
Although probably not the time or place you associate with government licensed cannabis shops, during the second half of the nineteenth century the colonial government of Bengal (modern day Bangladesh and West Bengal, India) regulated and taxed the sale of cannabis drugs in a manner that appears remarkably similar to many present day models and proposals.
Peter Hynd presents his work at the Cannabis: Global Histories conference at the University of Strathclyde, Glasgow, on April 19, 2018. Photo by Morgan Scott, Breathe Images
Continue reading →
Editor’s Note: Today we bring you a video of Chris Elcock discussing his work on the early years of cannabis legalization activism at the Cannabis: Global Histories conference held at the University of Strathclyde, Glasgow, in April 2018. Enjoy!
Chris Elcock – Global Histories: Cannabis from Points ADHS on Vimeo.
Editor’s Note: Today’s post comes from Dr. Chris Elcock, an adjunct professor at the Université Jean Moulin Lyon 3 in Lyon, France. His dissertation on the history of LSD in New York City is currently being expanded into a monograph. Here, his post deals with the early days of cannabis activism in the 1960s, and expands on the work he presented at the Cannabis: Global Histories conference held from April 19-20, 2018, at the University of Strathclyde, Glasgow. Enjoy!
It’s only a matter of time before the United States fully legalizes cannabis use on a federal level. More than thirty states now authorize medical marijuana and a handful have decriminalized it altogether, creating a lucrative business in the process. For the most part, this has been the result of popular initiative.
Chris Elcock presents his work at the Cannabis: Global Histories conference at the University of Strathclyde, Glasgow, on April 19, 2018. Photo by Morgan Scott, Breathe Images
The right to smoke pot not should be solely equated with the right to have fun, however. For many Americans, accessing marijuana for a variety of medical reasons seems like a fundamental right after decades of harsh penalties for possession of a plant that many Americans view as quite innocuous. Others believe that pot should be altogether decriminalized on libertarian grounds: the government should not tell them what they can and what they can’t put in their bodies. Still others think that states should remain sovereign and legislate on pot without the interference of the federal government.
Continue reading →
Editor’s Note: Today’s post comes from Lucas Richert and James H. Mills, professors at the University of Strathclyde in Glasgow and the organizers of the Cannabis: Global Histories conference, held April 19-20, 2018. They discuss the importance of developing a “big picture narrative” about the history of cannabis, and, as countries across the world reconsider marijuana laws, emphasize the need for this global approach. Enjoy!
Over the past decade governments in Uruguay, Portugal and the USA have made significant alterations to cannabis policies and other countries, such as Canada, have committed to major change this year. In 2018, Canada will be the first G7 country committed to ending cannabis prohibition at the federal level.
Ninety years after the UK imposed its own 1928 Coca Leaves and Indian Hemp Regulations, the Cannabis: Global Histories symposium at the University of Strathclyde, Glasgow addressed a range of historical questions about the origins of attitudes towards, policies on, and markets for cannabis substances. After all, by understanding how countries have come to the laws and control mechanisms that they currently deploy, and the reasons that consumers and suppliers have often proven to be so resistant to them, contemporary positions and future directions can be clearer, better-informed and free of the prejudices of the past.
Continue reading →
Anyone tuning in to Fox & Friends this week was treated to an awkward moment courtesy of Dr. Oz, when he went off-script after plugging his upcoming interview with Ivanka Trump and launched into an impassioned defense of medical marijuana.
“Can I ask you one thing? I talked about the opioid epidemic, but the real story is the hypocrisy around medical marijuana. And just really quickly, medical marijuana – people think it’s a gateway drug to narcotics but it may be the exit drug to get us out of the narcotic epidemic. But we’re not allowed, we’re not allowed to study it, because it’s a schedule I drug. And personally, I believe it could help.”
“Wow,” co-host Steve Doocy intoned, visibly tense. “Hadn’t heard that before.” He reminded viewers to watch Oz’s show and cut to commercial break, clearly wishing the cardiologist had taken co-host Brian Kilmeade’s cue to end the segment twenty seconds prior. Continue reading →